EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The landscape of biased agonism in aryl hydrocarbon receptor signaling: current clues and future directions

Zdeněk Dvořák, Jakub Přikryl

Frontiers in Pharmacology · 14.05.2026 · 17

DOI: 10.3389/fphar.2026.1823615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.05.2026. Verfasst von Zdeněk Dvořák und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Genetics, Faculty of Science, Palacký University, Olomouc, Czechia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agentura Pro Zdravotnický Výzkum České Republiky, Univerzita Palackého v Olomouci.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our understanding of the aryl hydrocarbon receptor (AhR) signaling pathway has significantly advanced since its initial discovery, revealing roles in both toxicology and normal physiological processes like immunity and organ development. However, key gaps remain concerning the precise mechanisms governing ligand-dependent canonical and non-canonical signaling. From a pharmacological standpoint, this involves the concept of functional selectivity, also known as biased agonism, where different ligands can selectively activate distinct downstream pathways, leading to different biological or toxicological outcomes. This paper reviews the current understanding of the formation, composition, and function of both cytosolic and nuclear AhR multiprotein complexes. We analyze the early and late cellular events that follow AhR ligand binding and explore new approaches aimed at the selective targeting of the AhR canonical and non-canonical signaling pathways for potential therapeutic benefit.

Schlagwörter

Stichwörter der Autor:innen

AhR receptorbiased agonismcellular signalingfunctional selectivitynon-canonical signaling pathway

Autor:innen und Institutionen

  • Department of Cell Biology and Genetics, Faculty of Science, Palacký University, Olomouc, Czechia.

Förderung

  • Agentura Pro Zdravotnický Výzkum České Republiky
  • Univerzita Palackého v Olomouci

Zitieren

APA

Dvořák, Z., & Přikryl, J. (2026). The landscape of biased agonism in aryl hydrocarbon receptor signaling: current clues and future directions. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1823615

Vancouver

Dvořák Z, Přikryl J. The landscape of biased agonism in aryl hydrocarbon receptor signaling: current clues and future directions. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1823615

BibTeX
@article{Dvok2026,
  author = {Dvořák, Zdeněk and Přikryl, Jakub},
  title = {The landscape of biased agonism in aryl hydrocarbon receptor signaling: current clues and future directions},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1823615}
}
Kostenlos starten →